BRAF Reactivity and BRAF Mutations in Pediatric Langerhans Cell Histiocytosis

被引：0
|
作者：
Saiji, Essia [1 ]
Biderbost, Christelle Cerato [1 ]
Berczy, Margaret [1 ]
Rougemont, Anne-Laure [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1840
引用
收藏
页码：464A / 465A
页数：2
相关论文
共 50 条
  • [31] BRAF V600E Immunohistochemistry in Cutaneous Langerhans Cell Histiocytosis
    Romano, R. C.
    Shon, W.
    Fritchie, K. L.
    LABORATORY INVESTIGATION, 2014, 94 : 142A - 142A
  • [32] Refractory Langerhans Cell Histiocytosis Treated with Cord Blood Transplantation and a BRAF Inhibitor
    Itakura, Yosuke
    Azumi, Shohei
    Kawaguchi, Koji
    Takachi, Takayuki
    Ogura, Taemi
    Horikoshi, Yasuo
    Kudo, Ko
    Terui, Kiminori
    Ito, Etsuro
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [33] BRAF V600E Immunohistochemistry in Cutaneous Langerhans Cell Histiocytosis
    Romano, R. C.
    Shon, W.
    Fritchie, K. L.
    MODERN PATHOLOGY, 2014, 27 : 142A - 142A
  • [34] BRAF-mutated histiocytosis of the skull lacking the expression of Langerhans cell markers
    El Sissy, Franck-Neil
    Lorillon, Gwenael
    Mandonnet, Emmanuel
    Polivka, Marc
    Addle-Biassette, Homa
    Emile, Jean-Francois
    CLINICAL NEUROPATHOLOGY, 2020, 39 (02) : 64 - 69
  • [35] DABRAFENIB FOR RESISTANT BRAF MUTATED MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Hays, Julia Allyson
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S19 - S20
  • [36] Vemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosis
    Haroche, Julien
    Cohen-Aubart, Fleur
    Emile, Jean-Francois
    Donadieu, Jean
    Amoura, Zahir
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) : E29 - E30
  • [37] The role of Braf-Mutated Hematopoietic cells in Patients with Langerhans cell Histiocytosis
    Hutter, Caroline
    Eder, Sebastian K.
    Schwentner, Raphaela
    Ben Soussia, Philipp
    Abagnale, Giulio
    Attarbaschi, Andishe
    Minkov, Milen
    Halbritter, Florian
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S10 - S11
  • [38] Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis
    Zarnegar, Sara
    Durham, Benjamin H.
    Khattar, Pallavi
    Shukla, Neerav N.
    Benayed, Ryma
    Lacouture, Mario E.
    Lavi, Ehud
    Lyden, David C.
    Diamond, Eli L.
    Dunkel, Ira J.
    Abdel-Wahab, Omar
    PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
  • [39] The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis
    Ballester, Leomar Y.
    Cantu, Miguel D.
    Lim, Karen P. H.
    Sarabia, Stephen F.
    Ferguson, Lizmery Suarez
    Webb, C. Renee
    Allen, Carl E.
    McClain, Kenneth L.
    Mohila, Carrie A.
    Punia, Jyotinder N.
    Roy, Angshumoy
    Lopez-Terrada, Dolores H.
    Hicks, M. John
    Fisher, Kevin E.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 307 - 315
  • [40] DETECTION OF BRAF MUTATIONS IN URINE AND PLASMA CELL-FREE DNA IN ERDHEIM-CHESTER DISEASE AND LANGERHANS CELL HISTIOCYTOSIS
    Diamond, Eli L.
    Abdel-Wahab, Omar
    Holley, Veronica R.
    Cabrilo, Goran
    Rampal, Raajit
    Hassaine, Latifa
    Kosco, Karena
    Baselga, Jose
    Kurzrock, Razelle
    Poole, Jason C.
    Erlander, Mark
    Vibat, Cecile Rose
    Janku, Filip
    Hyman, David M.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S6 - S6
12345